Asset
SCYLLO-INOSITOL
Revenue
No revenue reported in loaded filings.
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01791725 | phase2 | completed | 2013-09-01 | 2014-06-01 | OPKO Health, Inc. | A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia |
| NCT00934050 | phase2 | completed | 2009-06-01 | 2011-06-01 | OPKO Health, Inc. | ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease |
| NCT00568776 | phase2 | completed | 2007-12-01 | 2010-05-01 | OPKO Health, Inc. | ELND005 in Patients With Mild to Moderate Alzheimer's Disease |
| NCT01735630 | phase2 | completed | 2012-11-01 | 2015-05-01 | OPKO Health, Inc. | Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease |
| NCT01674010 | phase2 | terminated | 2012-08-01 | 2014-06-01 | OPKO Health, Inc. | Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder |
FDA applications (0)
This company has no applications containing this asset.